新和成(002001.SZ):已在山東啓動佔地約千畝用於佈局新產品
格隆匯6月27日丨新和成(002001.SZ)於近期投資者關係活動表示,目前公司香精香料板塊主要生產芳樟醇系列、檸檬醛系列、葉醇系列、二氫茉莉酮酸甲酯、薄荷醇等多種香料,被廣泛應用於個人護理、家庭護理、化妝品和食品領域。公司以客戶爲中心,產品品類豐富能滿足客戶不同需求,後續公司會通過持續優化產品結構、豐富香料產品品類,不斷推出一體化、系列化、協同化的香料新品種,持續提升產品核心競爭力,公司已在山東啓動佔地約千畝用於佈局新產品,相關項目正處於前期籌備和分階段審批流程中。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.